Spero Therapeutics' Series C Round

Spero Therapeutics raised a round of funding on March 08, 2017.

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a novel and highly differentiated pipeline of antibacterials focused on unmet needs of patie…

Articles about Spero Therapeutics' Series C Round: